X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3758) 3758
Book Review (845) 845
Publication (497) 497
Newsletter (124) 124
Book Chapter (20) 20
Conference Proceeding (12) 12
Book / eBook (5) 5
Newspaper Article (5) 5
Magazine Article (3) 3
Dissertation (2) 2
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3222) 3222
humans (3183) 3183
polycythemia-vera (2053) 2053
hematology (1914) 1914
female (1482) 1482
male (1472) 1472
janus kinase 2 - genetics (1465) 1465
mutation (1455) 1455
essential thrombocythemia (1391) 1391
middle aged (1248) 1248
aged (1074) 1074
adult (1022) 1022
oncology (998) 998
polycythemia vera - genetics (975) 975
myeloproliferative disorders (855) 855
myeloproliferative disorders - genetics (800) 800
tyrosine kinase jak2 (762) 762
myelofibrosis (743) 743
polycythemia vera (732) 732
polycythemia (621) 621
myeloproliferative neoplasms (608) 608
aged, 80 and over (596) 596
jak2 (578) 578
genetic aspects (531) 531
thrombocythemia, essential - genetics (530) 530
abridged index medicus (516) 516
animals (499) 499
leukemia (481) 481
primary myelofibrosis - genetics (481) 481
research (402) 402
primary myelofibrosis (387) 387
tumors (361) 361
myeloid metaplasia (356) 356
diagnosis (351) 351
hemic and lymphatic diseases (350) 350
disorders (346) 346
risk factors (343) 343
janus kinase 2 (337) 337
polycythemia vera - pathology (328) 328
mice (325) 325
adolescent (323) 323
thrombosis (323) 323
janus kinase 2 - metabolism (316) 316
prognosis (305) 305
polycythemia vera - diagnosis (295) 295
analysis (288) 288
cancer (276) 276
care and treatment (268) 268
myeloproliferative disorders - diagnosis (260) 260
chronic myeloproliferative disorders (259) 259
polycythemia vera - complications (257) 257
myeloproliferative disorders - pathology (255) 255
signal transduction (249) 249
young adult (245) 245
alleles (244) 244
jak2 v617f mutation (233) 233
polycythemia vera - drug therapy (232) 232
mutation, missense (230) 230
medicine & public health (227) 227
gene mutations (226) 226
amino acid substitution (225) 225
janus kinase 2 - antagonists & inhibitors (221) 221
acute myeloid-leukemia (220) 220
activating mutation (219) 219
expression (216) 216
pathology (216) 216
point mutation (216) 216
health aspects (215) 215
hematology, oncology and palliative medicine (215) 215
polycythemia vera - blood (211) 211
article (201) 201
cell biology (192) 192
primary myelofibrosis - pathology (192) 192
disease (191) 191
medicine, general & internal (187) 187
phenotype (187) 187
bone marrow (186) 186
chronic myeloid-leukemia (186) 186
dna mutational analysis (185) 185
thrombocythemia, essential - diagnosis (183) 183
v617f mutation (183) 183
bone marrow - pathology (181) 181
mutation - genetics (181) 181
proto-oncogene proteins - genetics (181) 181
disease progression (180) 180
receptors, thrombopoietin - genetics (179) 179
polymerase chain reaction (178) 178
child (177) 177
gene expression (172) 172
jak2v617f (172) 172
chromosome aberrations (171) 171
jak2 mutation (170) 170
retrospective studies (170) 170
thrombocythemia, essential - pathology (170) 170
stem cells (169) 169
hydroxyurea (167) 167
idiopathic myelofibrosis (167) 167
treatment outcome (166) 166
myeloproliferative disorders - drug therapy (163) 163
international working group (162) 162
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3748) 3748
French (30) 30
German (28) 28
Japanese (19) 19
Russian (19) 19
Chinese (13) 13
Spanish (10) 10
Danish (6) 6
Czech (5) 5
Hungarian (5) 5
Italian (5) 5
Korean (5) 5
Ukrainian (3) 3
Dutch (2) 2
Norwegian (2) 2
Portuguese (2) 2
Swedish (2) 2
Turkish (2) 2
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Cell, ISSN 1535-6108, 2005, Volume 7, Issue 4, pp. 387 - 397
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 7, pp. 601 - 612
Journal Article
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2017, Volume 92, Issue 1, pp. 94 - 108
Disease overview: Polycythemia Vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms respectively characterized by erythrocytosis and... 
ACUTE-LEUKEMIA | JAK2(V617F) MUTATION | MYELOFIBROSIS RESEARCH | LOW-DOSE ASPIRIN | LONG-TERM SURVIVAL | MYELOPROLIFERATIVE NEOPLASMS | CALRETICULIN MUTATIONS | DEFINED ESSENTIAL THROMBOCYTHEMIA | HEMATOLOGY | INTERFERON-ALPHA THERAPY | INTERNATIONAL WORKING GROUP | Primary Myelofibrosis - mortality | Humans | Polycythemia Vera - blood | Polycythemia Vera - genetics | Primary Myelofibrosis - pathology | Thrombocythemia, Essential - genetics | Calreticulin - genetics | Aspirin - administration & dosage | Erythropoietin - blood | Thrombocytosis - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aspirin - therapeutic use | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Thrombocytosis - pathology | Thrombocythemia, Essential - drug therapy | Primary Myelofibrosis - diagnosis | Diagnosis, Differential | Risk Assessment | Interferon-alpha - therapeutic use | Janus Kinase 2 - genetics | Hydroxyurea - administration & dosage | Thrombocythemia, Essential - blood | Polycythemia Vera - diagnosis | Thrombocytosis - diagnosis | Interferon-alpha - administration & dosage | Receptors, Thrombopoietin - genetics | Thrombocythemia, Essential - diagnosis | Hydroxyurea - therapeutic use | Polycythemia Vera - drug therapy | Mutation | Erythropoietin | Polycythemia | Leukemia | Diagnosis | Tumor proteins | Thrombosis | Risk factors | Blood clot | Pruritus | Age | Index Medicus
Journal Article